MTOR and congestive heart failure: The cardiac evaluation showed that only the value of LVM was reduced in patients of group B compared with Group A. This result underlines the protective effect of mTOR inhibitors on heart function, because LVM is the strongest predictor of the risk of subsequent congestive heart failure, a CV complication that can negatively affects the outcome of KTRs.